Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
CeNeS Pharmaceuticals plc (AIM: CEN), the biopharmaceutical company developing a new generation of pain management products, announces interim results for the six months ended 30 June 2006. In a separate announcement made today, CeNeS gives a more detailed update on its lead product for post-operative pain, M6G. ( www.cenes.com )
CeNeS Pharmaceuticals plc
Compass House, Vision Park Chivers Way, Histon
Cambridge, CB24 9ZR
United Kingdom
Tel: +44 1223 266466
Fax: +44 1223 266467